Treatment With Acoramidis Reduces Days Lost To Death And/or Cardiovascular-related Hospitalization, Preserving Time Alive Outside The Hospital In Patients With Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM

Attruby (acoramidis) - BridgeBio

https://eppro02.ativ.me/web/page.php?page=QuarentinedIntHtml&project=HFSA26&id=39

Richard Wright1; Jose Nativi-Nicolau2; Nitasha Sarswat3; Pooja Prasad4; Steen Hvitfeldt Poulsen5; Peter van der Meer6; Richard K. Cheng7; Martha Cao8; Jean-François Tamby9; Liana Hennum10; Heather Falvey11; Julian D. Gillmore12

Sep 7, 2026